MetaCap

Cardiol Therapeutics (CRDL) News

NASDAQ: CRDLHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.8626-0.0201 (-2.28%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CRDL news summary

We found 1 recent headline mentioning Cardiol Therapeutics (CRDL): 0 in the past week and 1 in the past 30 days, most often from PR Newswire. For price context, CRDL is down 2.28% at $0.8626. The most recent story, "Cardiol Therapeutics Announces At-The-Market Equity Offering Program With Jefferies LLC", was published by PR Newswire on Nov 3, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Cardiol Therapeutics headlines

Compare CRDL